Media Outlets Examine Politicization Of Novel Coronavirus Vaccine R&D, Ongoing Efforts To Develop Successful Product

DW: Is the U.S.-China rivalry tangling a coronavirus vaccine with geopolitics? (Rahn, 6/22).

The Guardian: Fear mounts Trump may pressure FDA to rush Covid-19 vaccine by election (McCarthy, 6/22).

New York Times: The Race to Develop a Covid Vaccine (Brody, 6/22).

New York Times: Coronavirus Attacks the Lungs. A Federal Agency Just Halted Funding for New Lung Treatments (Thomas/Stolberg, 6/19).

Reuters: Chinese researchers launch phase-2 human test for possible coronavirus vaccine (Liu/Lee, 6/21).

USA TODAY: Vaccines are not all created equal: a variety of ways to stop the virus that causes COVID-19 (Weintraub/Padilla, 6/22).

Wall Street Journal: Efforts for Coronavirus Vaccine Focus on Vulnerable Group: Older Adults (Hopkins, 6/21).

Washington Post: From Oxford to an Italian lab, one race for coronavirus vaccine is gaining backers (Harlan/Pitrelli, 6/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.